Wed, February 1, 2023
Tue, January 31, 2023
Mon, January 30, 2023
Sun, January 29, 2023
Fri, January 27, 2023

Edward Nash Maintained (TVTX) at Strong Buy with Increased Target to $40 on, Jan 30th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-40-on-jan-30th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Edward Nash of Canaccord Genuity, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $33 to $40 on, Jan 30th, 2023.

Edward has made no other calls on TVTX in the last 4 months.



There are 4 other peers that have a rating on TVTX. Out of the 4 peers that are also analyzing TVTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022


These are the ratings of the 3 analyists that currently disagree with Edward


  • Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $42 on, Wednesday, January 11th, 2023
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $38 on, Thursday, October 20th, 2022
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $36 on, Monday, October 17th, 2022

Publication Contributing Sources